Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report.

Girard N, Lou E, Azzoli CG, Reddy R, Robson M, Harlan M, Orlow I, Yatabe Y, Nafa K, Ladanyi M, Viale A, Kris MG, Riely G, Miller V, Klein RJ, Matsuo K, Pao W.

Clin Cancer Res. 2010 Jan 15;16(2):755-63. doi: 10.1158/1078-0432.CCR-09-2437. Epub 2010 Jan 12.

2.

Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer.

Schwartz AG, Cote ML, Wenzlaff AS, Land S, Amos CI.

J Thorac Oncol. 2009 Oct;4(10):1195-201. doi: 10.1097/JTO.0b013e3181b244ef.

3.

Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations.

Gazdar A, Robinson L, Oliver D, Xing C, Travis WD, Soh J, Toyooka S, Watumull L, Xie Y, Kernstine K, Schiller JH.

J Thorac Oncol. 2014 Apr;9(4):456-63. doi: 10.1097/JTO.0000000000000130.

4.

Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.

Truong T, Hung RJ, Amos CI, Wu X, Bickeböller H, Rosenberger A, Sauter W, Illig T, Wichmann HE, Risch A, Dienemann H, Kaaks R, Yang P, Jiang R, Wiencke JK, Wrensch M, Hansen H, Kelsey KT, Matsuo K, Tajima K, Schwartz AG, Wenzlaff A, Seow A, Ying C, Staratschek-Jox A, Nürnberg P, Stoelben E, Wolf J, Lazarus P, Muscat JE, Gallagher CJ, Zienolddiny S, Haugen A, van der Heijden HF, Kiemeney LA, Isla D, Mayordomo JI, Rafnar T, Stefansson K, Zhang ZF, Chang SC, Kim JH, Hong YC, Duell EJ, Andrew AS, Lejbkowicz F, Rennert G, Müller H, Brenner H, Le Marchand L, Benhamou S, Bouchardy C, Teare MD, Xue X, McLaughlin J, Liu G, McKay JD, Brennan P, Spitz MR.

J Natl Cancer Inst. 2010 Jul 7;102(13):959-71. doi: 10.1093/jnci/djq178. Epub 2010 Jun 14.

5.

Seizure 6-like (SEZ6L) gene and risk for lung cancer.

Gorlov IP, Meyer P, Liloglou T, Myles J, Boettger MB, Cassidy A, Girard L, Minna JD, Fischer R, Duffy S, Spitz MR, Haeussinger K, Kammerer S, Cantor C, Dierkesmann R, Field JK, Amos CI.

Cancer Res. 2007 Sep 1;67(17):8406-11.

6.

Frequencies of EGFR single nucleotide polymorphisms in non-small cell lung cancer patients and healthy individuals in the Republic of Serbia: a preliminary study.

Obradović J, Djordjević N, Tošic N, Mrdjanović J, Stanković B, Stanić J, Zarić B, Perin B, Pavlović S, Jurišić V.

Tumour Biol. 2016 Aug;37(8):10479-86. doi: 10.1007/s13277-016-4930-4. Epub 2016 Feb 5.

PMID:
26846215
7.

Association between CHRNA3 rs1051730 genotype and lung cancer risk in Chinese Han population: a case-control study.

Ren JH, Jin M, He WS, Liu CW, Jiang S, Chen WH, Yang KY, Wu G, Zhang T.

J Huazhong Univ Sci Technolog Med Sci. 2013 Dec;33(6):897-901. doi: 10.1007/s11596-013-1218-4. Epub 2013 Dec 13.

PMID:
24337855
8.

Correlation between polymorphisms of nicotine acetylcholine acceptor subunit CHRNA3 and lung cancer susceptibility.

Shen B, Shi MQ, Zheng MQ, Hu SN, Chen J, Feng JF.

Mol Med Rep. 2012 Dec;6(6):1389-92. doi: 10.3892/mmr.2012.1101. Epub 2012 Sep 26.

PMID:
23023782
9.

The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung.

Zienolddiny S, Skaug V, Landvik NE, Ryberg D, Phillips DH, Houlston R, Haugen A.

Carcinogenesis. 2009 Aug;30(8):1368-71. doi: 10.1093/carcin/bgp131. Epub 2009 May 22.

PMID:
19465454
10.

The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancer.

Toyooka S, Matsuo K, Shigematsu H, Kosaka T, Tokumo M, Yatabe Y, Ichihara S, Inukai M, Suehisa H, Soh J, Kiura K, Fong KM, Lee H, Wistuba II, Gazdar AF, Mitsudomi T, Date H.

Clin Cancer Res. 2007 Oct 1;13(19):5763-8.

11.

Association of smoking with tumor size at diagnosis in non-small cell lung cancer.

Chen X, Gorlov IP, Merriman KW, Weng SF, Foy M, Keener G, Amos CI, Spitz MR, Kimmel M, Gorlova OY.

Lung Cancer. 2011 Dec;74(3):378-83. doi: 10.1016/j.lungcan.2011.04.020. Epub 2011 Jun 8.

12.

Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.

Zhang W, Stabile LP, Keohavong P, Romkes M, Grandis JR, Traynor AM, Siegfried JM.

J Thorac Oncol. 2006 Sep;1(7):635-47.

13.

Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.

Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, Eisen T, Amos CI, Houlston RS.

Cancer Res. 2009 Aug 15;69(16):6633-41. doi: 10.1158/0008-5472.CAN-09-0680. Epub 2009 Aug 4.

14.

Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.

Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS.

Carcinogenesis. 2010 Feb;31(2):234-8. doi: 10.1093/carcin/bgp287. Epub 2009 Dec 2.

PMID:
19955392
15.

Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.

Carcereny E, Ramirez JL, Sanchez-Ronco M, Isla D, Cobo M, Moran T, de Aguirre I, Okamoto T, Wei J, Provencio M, Lopez-Vivanco G, Camps C, Domine M, Alberola V, Sanchez JM, Massuti B, Mendez P, Taron M, Rosell R.

Lung Cancer. 2010 Jun;68(3):491-7. doi: 10.1016/j.lungcan.2009.08.004. Epub 2009 Sep 5.

PMID:
19733931
16.

EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients.

Yang SY, Yang TY, Li YJ, Chen KC, Liao KM, Hsu KH, Tsai CR, Chen CY, Hsu CP, Hsia JY, Chuang CY, Tsai YH, Chen KY, Huang MS, Su WC, Chen YM, Hsiung CA, Shen CY, Chang GC, Yang PC, Chen CJ.

Int J Cancer. 2013 Jan 15;132(2):449-58. doi: 10.1002/ijc.27630. Epub 2012 Jun 28.

17.

Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese.

Shiraishi K, Kohno T, Kunitoh H, Watanabe S, Goto K, Nishiwaki Y, Shimada Y, Hirose H, Saito I, Kuchiba A, Yamamoto S, Yokota J.

Carcinogenesis. 2009 Jan;30(1):65-70. doi: 10.1093/carcin/bgn257. Epub 2008 Nov 12.

PMID:
19005185
18.

Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC.

Timofeeva MN, McKay JD, Smith GD, Johansson M, Byrnes GB, Chabrier A, Relton C, Ueland PM, Vollset SE, Midttun Ø, Nygård O, Slimani N, Romieu I, Clavel-Chapelon F, Boutron-Ruault MC, Fagherazzi G, Kaaks R, Teucher B, Boeing H, Weikert C, Bueno-de-Mesquita HB, van Gils C, Peeters PH, Agudo A, Barricarte A, Huerta JM, Rodríguez L, Sánchez MJ, Larrañaga N, Khaw KT, Wareham N, Allen NE, Travis RC, Gallo V, Norat T, Krogh V, Masala G, Panico S, Sacerdote C, Tumino R, Trichopoulou A, Lagiou P, Trichopoulos D, Rasmuson T, Hallmans G, Riboli E, Vineis P, Brennan P.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2250-61. doi: 10.1158/1055-9965.EPI-11-0496. Epub 2011 Aug 23.

19.

Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population.

Zhou H, Yang J, Li D, Xiao J, Wang B, Wang L, Ma C, Xu S, Ou X, Feng Y.

J Hum Genet. 2012 Nov 26;57(11):738-46. doi: 10.1038/jhg.2012.104. Epub 2012 Aug 23.

PMID:
22914670
20.

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.

Li Y, Sheu CC, Ye Y, de Andrade M, Wang L, Chang SC, Aubry MC, Aakre JA, Allen MS, Chen F, Cunningham JM, Deschamps C, Jiang R, Lin J, Marks RS, Pankratz VS, Su L, Li Y, Sun Z, Tang H, Vasmatzis G, Harris CC, Spitz MR, Jen J, Wang R, Zhang ZF, Christiani DC, Wu X, Yang P.

Lancet Oncol. 2010 Apr;11(4):321-30. doi: 10.1016/S1470-2045(10)70042-5. Epub 2010 Mar 19.

Supplemental Content

Support Center